C07K 14/26
Klebsiella
Official title: Klebsiella (G)
C07K14/26 (Klebsiella) appears on 75 US grants and 104 published applications in this corpus.
Search patents in C07K- Granted patents
- 75
- Published applications
- 104
- Assignees
- 52
- Inventors
- 212
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 5 |
| 2003 | 4 | 5 |
| 2004 | 2 | 5 |
| 2005 | 1 | 4 |
| 2006 | 1 | 3 |
| 2007 | 5 | 5 |
| 2008 | 3 | 1 |
| 2009 | 0 | 8 |
| 2010 | 4 | 4 |
| 2011 | 2 | 1 |
| 2012 | 2 | 2 |
| 2013 | 1 | 3 |
| 2014 | 3 | 3 |
| 2015 | 2 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 3 |
| 2018 | 3 | 2 |
| 2019 | 1 | 2 |
| 2020 | 4 | 5 |
| 2021 | 3 | 6 |
| 2022 | 1 | 6 |
| 2023 | 2 | 8 |
| 2024 | 3 | 7 |
| 2025 | 6 | 9 |
| 2026 | 7 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Klebsiella vaccine and methods of use11 Aug 2026US 12,702,704 B2Cornell University
- Proteins and immunizing compositions containing Klebsiella proteins and methods of use28 Jul 2026US 12,691,167 B2Vaxxinova US, Inc.
- Vaccine21 Jul 2026US 12,685,769 B2Glaxosmithkline Biologicals SA
- Klebicins for the control of Klebsiella16 Jun 2026US 12,655,181 B2Nomad Bioscience GmbH
- Modified bacterial strains for improved fixation of nitrogen2 Jun 2026US 12,643,837 B2Pivot Bio, Inc.
- Antibacterials24 Sep 2026US 2026/0285914 A1Oxford University Innovation Limited
- Immunogenic Composition20 Aug 2026US 2026/0240990 A1Glaxosmithkline Biologicals SA
- Csga-derived nanostructures and uses thereof for antigen delivery26 Mar 2026US 2026/0083834 A1
- Synthetic gene clusters15 Jan 2026US 2026/0015620 A1The Regents of the University of California
- Vaccine18 Dec 2025US 2025/0381257 A1Glaxosmithkline Biologicals SA
Most cited
By later US patents
- Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories181US 5,994,066 AInfectio Diagnostic, Inc. · 1999
- Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories178US 6,001,564 AInfectio Diagnostic, Inc. · 1999
- Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics80US 6,610,836 B1Genome Therapeutics Corporation · 2003
- Synthetic gene clusters33US 9,512,431 B2The Regents of the University of California · 2016
- Synthetic gene clusters29US 9,957,509 B2The Regents of the University of California · 2018